Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial - PubMed
3 hours ago
- #stroke care
- #clinical decision support system
- #ischaemic stroke
- The study evaluated the efficacy of a clinical decision support system (CDSS) on stroke care quality and clinical outcomes in patients with acute ischaemic stroke.
- A multicentre, cluster randomised clinical trial was conducted across 77 hospitals in China, involving 21,603 patients.
- The intervention group received CDSS support, including AI-assisted imaging analysis, stroke cause classification, and evidence-based treatment recommendations, while the control group received usual care.
- Primary outcome was a new vascular event within three months, which was significantly lower in the intervention group (2.9%) compared to the control group (3.9%).
- Secondary outcomes showed improved stroke care quality and reduced long-term vascular events in the intervention group, with no significant differences in disability, mortality, or bleeding events.
- The study concluded that the stroke CDSS significantly decreased new vascular events and improved stroke care quality in patients with acute ischaemic stroke in China.